Anika Therapeutics, Inc.
ANIK- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0000898437
In the last 90 days, Anika Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 133 institutions reported holding it in 13F filings for Q2 2026, worth $179.0M in total; no superinvestor holds it.
Holders of 5% or more of ANIK
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Anika Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Caligan Partners LP | 13D/A | 9.95%1.44M shares | 0.00 ppfrom 9.95% | Nov 21, 20252 filings | Jan 27, 2026 | SEC |
| BlackRock, Inc. | 13G/A | 6.80%963.1K shares | −3.80 ppfrom 10.60% | Feb 5, 20252 filings | Apr 17, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
26 Schedule 13D and 13G filings on Anika Therapeutics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Jul 31, 20269:56 AM ET | Vanguard Capital Management LLC | 13G/A | 4.95%659.2K shares | −0.24 ppfrom 5.19%Below 5% | Jun 30, 2026 | SEC |
| Jul 17, 202611:33 AM ET | BlackRock Portfolio Management LLC | 13G/A | 4.10%544.7K shares | −1.40 ppfrom 5.50%Below 5% | Jun 30, 2026 | SEC |
| Apr 29, 20264:35 PM ET | Vanguard Capital Management LLC | 13G | 5.19%695.7K shares | New | Mar 31, 2026 | SEC |
| Mar 26, 20263:45 PM ET | Vanguard Group Inc | 13G/A | 0.00%0 shares | –Below 5% | Mar 13, 2026 | SEC |
| Jan 27, 20267:29 PM ET | Caligan Partners LPand 1 other | 13D/A | 9.95%1.44M shares | 0.00 ppfrom 9.95% | Jan 23, 2026 | SEC |
| Jan 8, 20263:00 PM ET | Trigran Investments, Inc.and 5 others | 13G/A | 1.20%168.4K shares | −10.00 ppfrom 11.20%Below 5% | Dec 31, 2025 | SEC |
| Nov 21, 20259:21 AM ET | Caligan Partners LPand 1 other | 13D/A | 9.95%1.44M shares | – | Nov 19, 2025 | SEC |
| Nov 7, 20256:06 AM ET | Trigran Investments, Inc.and 5 others | 13G/A | 11.20%1.62M shares | – | Sep 30, 2025 | SEC |
| Oct 17, 202512:45 PM ET | BlackRock Portfolio Management LLC | 13G | 5.50%793.4K shares | New | Sep 30, 2025 | SEC |
| Apr 17, 20259:35 AM ET | BlackRock, Inc. | 13G/A | 6.80%963.1K shares | −3.80 ppfrom 10.60% | Mar 31, 2025 | SEC |
| Feb 5, 20255:28 PM ET | BlackRock, Inc. | 13G/A | 10.60%1.56M shares | – | Dec 31, 2024 | SEC |
| Jan 23, 20253:55 PM ET | Dimensional Fund Advisors LP | 13G/A | 4.50%657.4K shares | –Below 5% | Dec 31, 2024 | SEC |
| Mar 6, 2024 | Caligan Partners LP | 13D/AOld format | – | – | – | SEC |
| Feb 13, 2024 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2024 | Trigran Investments, Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2024 | Dimensional Fund Advisors LP | 13G/AOld format | – | – | – | SEC |
| Jan 22, 2024 | State Street Corp | 13G/AOld format | – | – | – | SEC |
| Oct 6, 20232:34 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Sep 11, 2023 | Caligan Partners LP | 13D/AOld format | – | – | – | SEC |
| Aug 17, 2023 | Caligan Partners LP | 13DOld format | – | New | – | SEC |
| Feb 14, 202310:33 AM ET | Ameriprise Financial Inc | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2023 | Trigran Investments, Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2023 | Dimensional Fund Advisors LP | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2023 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 8, 2023 | State Street Corp | 13G/AOld format | – | – | – | SEC |
| Jan 26, 20238:52 AM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Jan 20, 20239:43 AM ET | BlackRock Inc. | 13GOld format | – | – | – | SEC |
| Oct 7, 2022 | Trigran Investments, Inc. | 13GOld format | – | New | – | SEC |
| Jun 9, 2022 | Kayne Anderson Rudnick Investment Management LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 202212:27 PM ET | Ameriprise Financial Inc | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Kayne Anderson Rudnick Investment Management LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Avidity Partners Management LP | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2022 | Renaissance Technologies LLC | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2022 | State Street Corp | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2022 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 8, 2022 | Dimensional Fund Advisors LP | 13G/AOld format | – | – | – | SEC |
| Jan 27, 20221:59 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Jan 25, 20226:45 PM ET | BlackRock Inc. | 13GOld format | – | – | – | SEC |
| Feb 16, 2021 | Avidity Partners Management LP | 13GOld format | – | New | – | SEC |
| Feb 12, 20219:45 AM ET | Ameriprise Financial Inc | 13GOld format | – | New | – | SEC |
| Feb 12, 2021 | Dimensional Fund Advisors LP | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2021 | Kayne Anderson Rudnick Investment Management LLC | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2021 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2021 | Renaissance Technologies LLC | 13GOld format | – | New | – | SEC |
| Feb 5, 2021 | State Street Corp | 13GOld format | – | New | – | SEC |
| Jan 25, 20214:56 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Anika Therapeutics, Inc. shares.
No Form 144 notices for Anika Therapeutics, Inc. are on file.